Chargement en cours...
Randomized Trial Assessing the Effects of Ergocalciferol Administration on Circulating FGF23
BACKGROUND AND OBJECTIVES: Fibroblast growth factor 23 is a phosphate- and vitamin D–regulating hormone. The objective of this study was to determine the effect of ergocalciferol administration on fibroblast growth factor 23 levels in healthy vitamin D–deficient subjects. DESIGN, SETTING, PARTICIPAN...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3315336/ https://ncbi.nlm.nih.gov/pubmed/22300739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.10030911 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|